Comment
doi: 10.1056/NEJMc1616637.
T-Cell Transfer Therapy Targeting Mutant KRAS
Affiliations
- PMID: 28207208
- DOI: 10.1056/NEJMc1616637
Item in Clipboard
Comment
T-Cell Transfer Therapy Targeting Mutant KRAS
N Engl J Med.
.
No abstract available
Comment in
-
T-Cell Transfer Therapy Targeting Mutant KRAS.N Engl J Med. 2017 Feb 16;376(7):e11. N Engl J Med. 2017. PMID: 28199803 Free PMC article. No abstract available.
Comment on
-
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer.N Engl J Med. 2016 Dec 8;375(23):2255-2262. doi: 10.1056/NEJMoa1609279. N Engl J Med. 2016. PMID: 27959684 Free PMC article.
Similar articles
-
T-Cell Transfer Therapy Targeting Mutant KRAS.N Engl J Med. 2017 Feb 16;376(7):e11. N Engl J Med. 2017. PMID: 28199803 Free PMC article. No abstract available.
-
T-Cell Transfer Therapy Targeting Mutant KRAS.N Engl J Med. 2017 Feb 16;376(7):e11. doi: 10.1056/NEJMc1616637. N Engl J Med. 2017. PMID: 28207209 Free PMC article. No abstract available.
-
Mutant RAS Calms Stressed-Out Cancer Cells.Dev Cell. 2017 Jan 23;40(2):120-122. doi: 10.1016/j.devcel.2017.01.005. Dev Cell. 2017. PMID: 28118599 Free PMC article.
-
KRAS mutations in non-small cell lung cancer.Proc Am Thorac Soc. 2009 Apr 15;6(2):201-5. doi: 10.1513/pats.200809-107LC. Proc Am Thorac Soc. 2009. PMID: 19349489 Review.
-
The clinical relevance of KRAS gene mutation in non-small-cell lung cancer.Curr Opin Oncol. 2014 Mar;26(2):138-44. doi: 10.1097/CCO.0000000000000051. Curr Opin Oncol. 2014. PMID: 24463346 Review.
Cited by
-
Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer.Front Immunol. 2021 Aug 24;12:723566. doi: 10.3389/fimmu.2021.723566. eCollection 2021. Front Immunol. 2021. PMID: 34504498 Free PMC article.
-
Neo-Antigen-Reactive T Cells Immunotherapy for Colorectal Cancer: A More Personalized Cancer Therapy Approach.Glob Chall. 2023 Oct 17;7(11):2200186. doi: 10.1002/gch2.202200186. eCollection 2023 Nov. Glob Chall. 2023. PMID: 37970536 Free PMC article. Review.
-
Conquering oncogenic KRAS and its bypass mechanisms.Theranostics. 2022 Jul 18;12(13):5691-5709. doi: 10.7150/thno.71260. eCollection 2022. Theranostics. 2022. PMID: 35966590 Free PMC article. Review.
-
Adoptive Cell Transfer: Is it a Promising Immunotherapy for Colorectal Cancer?Theranostics. 2018 Nov 10;8(20):5784-5800. doi: 10.7150/thno.29035. eCollection 2018. Theranostics. 2018. PMID: 30555581 Free PMC article. Review.
-
Therapeutic Targets of KRAS in Colorectal Cancer.Cancers (Basel). 2021 Dec 11;13(24):6233. doi: 10.3390/cancers13246233. Cancers (Basel). 2021. PMID: 34944853 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
